Till startsida
University of Gothenburg
Sitemap
To content Read more about how we use cookies on gu.se

Ongoing studies

Clinical

  • A clinical trial (phase II study) with IGF-I/IGFBP-3 administration www.clinicaltrials.gov NCT 01096784
  • A clinical trial (Donna Mega) to investigate the impact of DHA/EPA on retinophaty, visual and neural development EUDRA-CT no 2008-000046-31
  • A clinical trial (Mega Donna Mega) to investigate the impact of AA/DHA on retinopathy, visual and neural development.
  • Further validation of WINROP® (national & international)
  • Ophthalmologic follow-up studies of infants with perinatal adverse history
  • Investigating the impact of postnatal serum IGF-I levels on preterm morbidity and postnatal growth
  • Effect of blood components importance for neuro- and angiogenesis in premature infants
  • Metabolic and Pharmakoninetic analysis of intravenous insulin administration to very preterm infants
  • Development of a digiatal e-health solution for ROP screening and diagnosis
     

Experimental

  • Investigating the impact of chronic inflammation on ROP development in an experimental neonatal animal model
  • A proteomic and luminex approach for identification of biomarkers in amnion, cord blood and serum that may predict an increased risk for ROP

 

Kurva
DONNA MEGA
Page Manager: Carola Pfeiffer Mosesson|Last update: 6/21/2018
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?